Next-Generation Sequencing Services Market (By Service Type: Human Genome Sequencing, Gene Regulation Services; By Workflow: Pre-sequencing, Sequencing, Data Analysis; By End-use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and End-use Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Next-Generation Sequencing Services Market 

5.1. COVID-19 Landscape: Flow Computers Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Next-Generation Sequencing Services Market, By Service Type

8.1. Next-Generation Sequencing Services Market, by Service Type Type, 2022-2030

8.1.1. Human Genome Sequencing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Single Cell Sequencing

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Microbial Genome-based Sequencing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Gene Regulation Services

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Small RNA Sequencing

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. ChIP Sequencing

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Other Gene Regulation-based Services

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Animal & Plant Sequencing

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Other Sequencing Services

8.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Next-Generation Sequencing Services Market, By Workflow

9.1. Next-Generation Sequencing Services Market, by Workflow, 2022-2030

9.1.1. Pre-sequencing

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Sequencing

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Data Analysis

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Next-Generation Sequencing Services Market, By End-use Channel 

10.1. Next-Generation Sequencing Services Market, by End-use Channel, 2022-2030

10.1.1. Universities & Other Research Entities

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hospitals & Clinics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Pharma & Biotech Entities

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Next-Generation Sequencing Services Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.1.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.2.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.3.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Service Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Workflow (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-use Channel (2017-2030)

Chapter 12. Company Profiles

12.1. Illumina, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Veritas Genetics

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BGI

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. GENEWIZ Germany GmbH

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. ABM Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ARUP Laboratories

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Novogene Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Lucigen

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Quest Diagnostics

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Gene by Gene

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms